Ieq Capital, LLC Blueprint Medicines Corp Transaction History
Ieq Capital, LLC
- $10.1 Billion
- Q4 2024
A detailed history of Ieq Capital, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ieq Capital, LLC holds 10,163 shares of BPMC stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,163Holding current value
$1.05 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
362Shares Held
62.7MCall Options Held
2.24MPut Options Held
1.15M-
Vanguard Group Inc Valley Forge, PA6.77MShares$702 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$688 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$558 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$443 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$286 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.18B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...